I. Alex Bowman

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen et al. · The Lancet Oncology · 2019 · 173 citations

Urology, Genitourinary Cancer, Kidney Research +8

Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma

Laure Hirsch, Nieves Martínez Chanzá, Subrina Farah et al. · JAMA Oncology · 2021 · 93 citations · Full text

Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer

Yuanyuan Zhang, Jonathan E. Schoenhals, Alana Christie et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 92 citations · Full text

Urology, Defer Systemic Therapy, Radiation Therapy +4

Pancreatic tropism of metastatic renal cell carcinoma

Nirmish Singla, Zhiqun Xie, Ze Zhang et al. · JCI Insight · 2020 · 81 citations · Full text

Urology, Pancreatic Cancer, Genitourinary Cancer +13